Ann K. Miller

1.0k total citations
28 papers, 806 citations indexed

About

Ann K. Miller is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ann K. Miller has authored 28 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Ann K. Miller's work include Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Ann K. Miller is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Ann K. Miller collaborates with scholars based in United States, United Kingdom and Switzerland. Ann K. Miller's co-authors include Martin I. Freed, David Ryan, Hugh Cowley, Peter J. Cox, F. J. Hollis, A S Harris, Horace F. Russo, W. F. Verwey, Karl H. Beyer and Diane K. Jorkasky and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ann K. Miller

27 papers receiving 754 citations

Peers

Ann K. Miller
D. Brockmeier Germany
B.K. Park United Kingdom
Kelly Rose United States
Chakradhara Rao S. Uppugunduri Switzerland
Justina C. Calamia United States
P W Lücker Germany
Sang‐Goo Shin South Korea
L. Giuliani Italy
Warren P. Bishop United States
Klaus Kutz Switzerland
D. Brockmeier Germany
Ann K. Miller
Citations per year, relative to Ann K. Miller Ann K. Miller (= 1×) peers D. Brockmeier

Countries citing papers authored by Ann K. Miller

Since Specialization
Citations

This map shows the geographic impact of Ann K. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann K. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann K. Miller more than expected).

Fields of papers citing papers by Ann K. Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann K. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann K. Miller. The network helps show where Ann K. Miller may publish in the future.

Co-authorship network of co-authors of Ann K. Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Ann K. Miller. A scholar is included among the top collaborators of Ann K. Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann K. Miller. Ann K. Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Geon, Meaghan Boileau, Thuy T. P. Nguyen, et al.. (2024). In Vivo barcoded CRISPR-Cas9 Screen Identifies Ncoa4-mediated Ferritinophagy As a Dependence in Tet2-Deficient Haemopoiesis. Blood. 144(Supplement 1). 188–188.
2.
Kim, Dong Won, et al.. (2021). Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma. AACE Clinical Case Reports. 7(3). 169–173. 4 indexed citations
3.
Miller, Ann K. & Kristi D. Silver. (2019). Thyroid Storm with Multiorgan Failure Treated with Plasmapheresis. Case Reports in Endocrinology. 2019. 1–5. 11 indexed citations
4.
Rueangweerayut, Ronnatrai, Germana Bancone, Andrew P. Beelen, et al.. (2017). Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers. American Journal of Tropical Medicine and Hygiene. 97(3). 702–711. 72 indexed citations
5.
Miller, Ann K., Ye Li, Jőrg‐Peter Kleim, et al.. (2013). Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. British Journal of Clinical Pharmacology. 76(6). 858–867. 36 indexed citations
6.
Sundar, Shyam, et al.. (2011). Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India. American Journal of Tropical Medicine and Hygiene. 84(6). 892–900. 20 indexed citations
7.
Sisay-Joof, Fatoumatta, Archibald Worwui, Paul Milligan, et al.. (2009). Effects of Genetic Variation at the CYP2C19 / CYP2C9 Locus on Pharmacokinetics of Chlorcycloguanil in Adult Gambians. Pharmacogenomics. 10(9). 1423–1431. 12 indexed citations
8.
Miller, Ann K., Nibedita Bandyopadhyay, Dan Wootton, et al.. (2009). Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria. European Journal of Clinical Pharmacology. 65(10). 977–987. 9 indexed citations
9.
Charles, Bruce, Ann K. Miller, Peter Nasveld, et al.. (2007). Population Pharmacokinetics of Tafenoquine during Malaria Prophylaxis in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 51(8). 2709–2715. 27 indexed citations
10.
Miller, Ann K., et al.. (2003). Pharmacokinetics of Rosiglitazone in Patients with Varying Degrees of Renal Insufficiency. The Journal of Clinical Pharmacology. 43(3). 252–259. 68 indexed citations
11.
Miller, Ann K., et al.. (2002). The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers. Clinical Therapeutics. 24(7). 1062–1071. 18 indexed citations
12.
Miller, Ann K., et al.. (2001). Lack of Effect of Rosiglitazone on the Pharmacokinetics of Oral Contraceptives in Healthy Female Volunteers. The Journal of Clinical Pharmacology. 41(6). 683–690. 21 indexed citations
13.
Miller, Ann K., et al.. (2001). The effect of acarbose on the pharmacokinetics of rosiglitazone. European Journal of Clinical Pharmacology. 57(2). 105–109. 23 indexed citations
14.
Cox, Peter J., David Ryan, F. J. Hollis, et al.. (2000). Absorption, Disposition, and Metabolism of Rosiglitazone, a Potent Thiazolidinedione Insulin Sensitizer, in Humans. Drug Metabolism and Disposition. 28(7). 772–780. 176 indexed citations
15.
Miller, Ann K., et al.. (2000). Rosiglitazone Does Not Affect the Steady‐State Pharmacokinetics of Digoxin. The Journal of Clinical Pharmacology. 40(12). 1516–1521. 13 indexed citations
16.
Nix, David E., Ann K. Miller, Steven C. Boike, et al.. (1999). The Effect of Low‐Dose Cimetidine (200 mg Twice Daily) on the Pharmacokinetics of Theophylline. The Journal of Clinical Pharmacology. 39(8). 855–865. 3 indexed citations
17.
Harris, Robert Z., Ann K. Miller, Kathleen Thompson, et al.. (1999). Rosiglitazone Has No Clinically Significant Effect on Nifedipine Pharmacokinetics. The Journal of Clinical Pharmacology. 39(11). 1189–1194. 32 indexed citations
18.
Tenero, David M., David E. Martin, Ann K. Miller, et al.. (1998). Effect of age and gender on the pharmacokinetics of eprosartan. British Journal of Clinical Pharmacology. 46(3). 267–270. 17 indexed citations
19.
Miller, Ann K., Joseph Adir, & Robert E. Vestal. (1990). Excretion of tolbutamide metabolites in young and old subjects. European Journal of Clinical Pharmacology. 38(5). 523–524. 13 indexed citations
20.
Adir, Joseph, Ann K. Miller, & Robert E. Vestal. (1982). Effects of total plasma concentration and age on tolbutamide plasma protein binding. Clinical Pharmacology & Therapeutics. 31(4). 488–493. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Brockmeier Breakdown of academic impact, for papers by B.K. Park Breakdown of academic impact, for papers by Kelly Rose Breakdown of academic impact, for papers by Chakradhara Rao S. Uppugunduri Breakdown of academic impact, for papers by Justina C. Calamia Breakdown of academic impact, for papers by P W Lücker Breakdown of academic impact, for papers by Sang‐Goo Shin Breakdown of academic impact, for papers by L. Giuliani Breakdown of academic impact, for papers by Warren P. Bishop Breakdown of academic impact, for papers by Klaus Kutz
Rankless by CCL
2026